Birchview Capital, LP Myriad Genetics Inc Transaction History

Birchview Capital, LP

  • $108 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 12, 2020
SELL
$9.78 - $29.53 $293,400 - $885,900
-30,000 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$22.08 - $47.08 $220,799 - $470,800
10,000 Added 50.0%
30,000 $859,000
Q1 2019

May 03, 2019
BUY
$26.93 - $34.7 $269,300 - $347,000
10,000 Added 100.0%
20,000 $664,000
Q1 2018

May 07, 2018
BUY
$28.83 - $41.01 $288,300 - $410,100
10,000 New
10,000 $296,000

Others Institutions Holding MYGN

# of Institutions
249
Shares Held
90.6M
Call Options Held
100K
Put Options Held
34K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.01B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email